M.C. Manara; G. Nicoletti; D. Zambelli; S. Ventura; C. Guerzoni; L. Landuzzi; P.-L. Lollini; S.-M. Maira; C. Garcia-Echeverria; M. Mercuri; P. Picci; K. Scotlandi, NVE-BEZ235 as a new therapeutic option for sarcomas., «CLINICAL CANCER RESEARCH», 2010, 16 (2), pp. 530 - 540 [articolo]
Soverini, Simona; Gnani, Alessandra; Colarossi, Sabrina; Vitale, Antonella; Castagnetti, Fausto; Palandri, Francesca; Paolini, Stefania; Papayannidis, Cristina; Amabile, Marilina; Iacobucci, Ilaria; Poerio, Angela; Scotlandi, Katia; Lonetti, Annalisa; Mandelli, Franco; Baccarani, Michele; Foà, Robin; Martinelli, Giovanni, Low level mutations in the Bcr-Abl kinase domain may already be detected at diagnosis both in patients with Philadelphia-positive acute lymphoblastic leukemia and in patients with chronic phase chronic myeloid leukemia, in: Volume 69, Issue 9 Supplement, «CANCER RESEARCH», 2009, pp. 3871 - 3871 (atti di: AACR Annual Meeting, Denver, CO, Apr 18-22, 2009) [atti di convegno-abstract]
Bacci G.; Boriani S.; Balladelli A.; Barbieri E.; Longhi A.; Alberghini M.; Scotlandi K.; Forni C.; Pollastri P.; Vanel D.; Mercuri M., Treatment of nonmetastatic Ewing's sarcoma family tumors of the spine and sacrum: the experience of a single institution, «EUROPEAN SPINE JOURNAL», 2009, 18(8), pp. 1091 - 1095 [articolo]
Zucchini C.; Rocchi A.; Manara M.C.; De Sanctis P.; Capanni C.; Bianchini M.; Carinci P.; Scotlandi K.; Valvassori L., Apoptotic genes as potential markers of metastatic phenotype in human osteosarcoma cell lines., «INTERNATIONAL JOURNAL OF ONCOLOGY», 2008, 32(1), pp. 17 - 31 [articolo]
Capanni C; Del Coco R; Squarzoni S; Columbaro M; Mattioli E; Camozzi D; Rocchi A; Scotlandi K; Maraldi N; Foisner R; Lattanzi G., Prelamin A is involved in early steps of muscle differentiation., «EXPERIMENTAL CELL RESEARCH», 2008, 314, pp. 3628 - 3637 [articolo]
Cantiani L.; Manara M.C.; Zucchini C.; De Sanctis P.; Zuntini M.; Valvassori L.; Serra M.; Olivero M.; Di Renzo M.F.; Colombo M.P.; Picci P.; Scotlandi K., Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling, «CANCER RESEARCH», 2007, 67(16), pp. 7675 - 7685 [articolo]
Scotlandi K; Zuntini M; Manara MC; Sciandra M; Rocchi A; Benini S; Nicoletti G; Bernard G; Nanni P; Lollini PL; Bernard A; Picci P, CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity, «ONCOGENE», 2007, 26, pp. 6604 - 6618 [articolo]
M.C. Manara; L. Landuzzi; P. Nanni; G. Nicoletti; D. Zambelli; P.L. Lollini; C. Nanni; F. Hofmann; C. García-Echeverría; P. Picci; K. Scotlandi., Preclinical in vivo study of new insulin-like growth factor-I receptor-specific inhibitor in Ewing’s sarcoma., «CLINICAL CANCER RESEARCH», 2007, 13, pp. 1322 - 1330 [articolo]
Manara M.C.; Bernard G.; Lollini P.L.; Nanni P.; Zuntini M.; Landuzzi L.; Benini S.; Lattanzi G.; Sciandra M.; Serra M.; Colombo M.P.; Bernard A.; Picci P.; Scotlandi K., CD99 Acts as an Oncosuppressor in Osteosarcoma., «MOLECULAR BIOLOGY OF THE CELL», 2006, 17, pp. 1910 - 1921 [articolo]
S. Benini; M. Zuntini; M.C. Manara; P. Cohen; G. Nicoletti; P. Nanni; Y Oh; P. Picci; K. Scotlandi, Insulin-like growth factor binding protein 3 as an anti-cancer molecule in Ewing's sarcoma., «INTERNATIONAL JOURNAL OF CANCER», 2006, 119, pp. 1039 - 1046 [articolo]
Serra M.; Pasello M.; Manara MC.; Scotlandi K.; Ferrari S.; Bretoni F.; Mercuri M.; et al., May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian /Scandinavian Sarcoma Group 1 treatment protocol, «INTERNATIONAL JOURNAL OF ONCOLOGY», 2006, 29(6), pp. 68 - 1459 [articolo]
K. Scotlandi; S. Perdichizzi; G. Bernard; G. Nicoletti; P. Nanni; P.-L. Lollini; A. Curti; M. C. Manara; S. Benini; A. Bernard; P. Picci, Targeting CD99 in association with doxorubicin: An effective combined treatment for Ewing’s sarcoma, «EUROPEAN JOURNAL OF CANCER», 2006, 42, pp. 91 - 96 [articolo]
Scotlandi K; Manara MC; Nicoletti G; Lollini PL; Lukas S; Benini S; Croci S; Perdichizzi S; Zambelli D; Serra M; Garcia-Echeverria C; Hofmann F; Picci P., Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors., «CANCER RESEARCH», 2005, 65, pp. 3868 - 3876 [articolo]
Chano T; Mori K; Scotlandi K; Benini S; Lapucci C; Manara MC; Serra M; Picci P; Okabe H; Baldini N., Differentially expressed genes in multidrug resistant variants of U-2 OS human osteosarcoma cells., «ONCOLOGY REPORTS», 2004, 11, pp. 1257 - 1263 [articolo]
C.M. Hattinger; M. Pasello; D. Remondini; G.C. Castellani; S. Benini; M.C. Manara; G. Stoico; K. Scotlandi; P. Picci; M. Serra, Gene amplification is associated with methotrexate resistance in human osteosarcoma cell lines, in: , 2004, 16 Suppl 1, pp. 175 - 175 (atti di: First ISC International Conference on Cancer Therapeutics (Molecular Targets, Pharmacology and Clinical Applications), Florence, Italy, February 2004,) [Contributo in Atti di convegno]
